E. Sagnelli et al., HCV genotype and "silent" HBV coinfection: Two main risk factors for a more severe liver disease, J MED VIROL, 64(3), 2001, pp. 350-355
To evaluate whether HCV genotype and a "silent" HBV infection may be relate
d to a more severe clinical presentation of liver disease, 205 anti-HCV/HCV
-RNA positive, HBsAg/anti-HBs negative patients with chronic hepatitis (113
males and 92 females; median age 55 years, range 18-77), were studied on p
resentation at the Liver Unit from January 1993 to December 1997. Presence
of serum anti-HBc, in the absence of HBsAg and anti-HBs, was considered a m
arker of "silent" HBV infection. Of the 205 patients, 134 had undergone per
cutaneous liver biopsy. Two main diagnosis groups were established: the mil
d liver disease group (76 patients), and the severe liver disease group (10
9 patients); 20 patients who had refused to undergo liver biopsy were not i
ncluded in the clinical and virological evaluation because the diagnosis wa
s uncertain. The prevalence of severe liver disease was similar in the geno
type 1 and non-1 groups (61.3% of 98 patients with genotype 1 and 52.9% of
70 patients with a non-1 genotype). Instead, the 88 patients with "silent"
HBV infection showed a higher percentage of severe liver disease than the 9
7 anti-HBc negative patients (72.7% vs. 46.4%, respectively: P <0.0005). Of
the 88 anti-HBc positive patients, the prevalence of those with severe liv
er disease was similar in the 32 cases with serum HBV-DNA as detected by PC
R and in the 56 HBV-DNA negative (81.2% vs. 67.8%, P=0.4). The relation bet
ween "silent" HBV infection and severe liver disease was observed both in g
enotype 1 and non-1 infected patients. Nevertheless, the anti-HBc negative
patients infected by genotype 1 showed a severe liver disease more frequent
ly than those infected by a non-1 genotype, with a difference that is signi
ficant to the statistical analysis (P <0.05). The findings suggest that "si
lent" HBV infection in anti-HCV positive chronic hepatitis enhances the sev
erity of the liver disease. Evidence was also found that in patients withou
t "silent" HBV infection there is a correlation between the presence of HCV
genotype 1 and the severity of liver disease. (C) 2001 Wiley-Liss, Inc.